1 / 2

Western Blotting Market and the Increasing Demand for Personalized Medicine

The western blotting market is projected to reach USD 730.7 Million by 2021 from USD 574.8 Million in 2016, at a CAGR of 4.9% in the next five years (2016 to 2021).<br><br>For more details : https://www.marketsandmarkets.com/Market-Reports/western-blotting-market-235810711.html

healthcaremarket
Télécharger la présentation

Western Blotting Market and the Increasing Demand for Personalized Medicine

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Western Blotting Market and the Increasing Demand for Personalized Medicine According to the new market research report "Western Blotting Market by Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies) - Global Forecasts to 2021",published by MarketsandMarkets™,The western blotting market is projected to reach USD 730.7 Million by 2021 from USD 574.8 Million in 2016, at a CAGR of 4.9% in the next five years (2016 to 2021). Browse in-depth TOC on “Western Blotting Market" 132 - Table 41 – Figures 169 – Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=235810711 In the coming years, the western blotting market is expected to witness the highest growth in the Asia- Pacific region. This can be attributed to increasing government interest in biomedical & biotechnology industry in China, government initiatives supported by funding in Japan, growing funding for agriculture research in India, increasing diagnosis and related funding in Australia, and growing prevalence of herpes simplex virus (HSV) in southeast Asia. New product launches was the major growth strategy adopted by players in the western blotting market. The western blotting market is dominated by Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), and GE Healthcare (U.S.). Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=235810711 These players jointly accounted for approximately 80% of the market in 2016. Other players having significant presence in this market include Advasta, Inc. (U.S.), LI-COR Biosciences (U.S.), PerkinElmer, Inc. (U.S.), Bio-Techne Corporation (U.S.), Merck KGaA (Germany), F. Hoffmann-La Roche Ltd.

  2. (Switzerland), and Cell Signaling Technology, Inc. (U.S.).). Bio-Rad Laboratories, Inc. is the leading player in the western blotting market. The company is a leading manufacturer and supplier of products and systems to separate, detect, analyze, and purify complex biological and chemical materials. The company serves the fields of life science research, healthcare, and analytical chemistry with its innovative products and services. The company’s leading position in the market can be attributed to its wide customer base. Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=235810711

More Related